Sunshine Biopharma, Inc. (NASDAQ:SBFMW – Get Free Report) traded up 22.8% during mid-day trading on Tuesday . The stock traded as high as $0.2453 and last traded at $0.2453. 6,800 shares were traded during trading, a decline of 52% from the average session volume of 14,120 shares. The stock had previously closed at $0.1997.
Sunshine Biopharma Stock Performance
The company has a 50-day simple moving average of $0.21 and a 200-day simple moving average of $0.22.
Sunshine Biopharma Company Profile
Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.
Featured Stories
- Five stocks we like better than Sunshine Biopharma
- What is a Low P/E Ratio and What Does it Tell Investors?
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Sunshine Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
